Horizon Therapeutics PLC (HZNP)

Add to Watchlists
Create an Alert
Quickflows
68.91 -0.13  -0.19% NASDAQ Nov 25, 17:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All HZNP News

News

View All Events

Events

Date Type Description
02/26/2021 Earnings Horizon Therapeutics PLC Fourth Quarter Earnings for 2020 Release
02/26/2021 08:00 EST Misc Horizon Therapeutics PLC Fourth Quarter Earnings Conference Call for 2020
11/02/2020 Earnings Horizon Therapeutics PLC Third Quarter Earnings Result for 2020
11/02/2020 08:00 EST Misc Horizon Therapeutics PLC Third Quarter Earnings Conference Call for 2020
08/05/2020 08:00 EDT Misc Horizon Therapeutics PLC Second Quarter Earnings Conference Call for 2020
08/05/2020 Earnings Horizon Therapeutics PLC Second Quarter Earnings Result for 2020
05/06/2020 08:00 EDT Misc Horizon Therapeutics PLC First Quarter Earnings Conference Call for 2020
05/06/2020 Earnings Horizon Therapeutics PLC First Quarter Earnings Result for 2020
04/30/2020 Misc Horizon Therapeutics PLC Annual General Meeting for 2019
02/26/2020 08:00 EST Misc Horizon Therapeutics PLC Fourth Quarter Earnings Conference Call for 2019
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 1.819B
Total Expenses (TTM) 1.514B
Net Income (TTM) 792.01M

Balance Sheet View Statement

Total Assets (Quarterly) 5.767B
Total Liabilities (Quarterly) 1.970B
Shareholders Equity (Quarterly) 3.797B

Cash Flow Statement View Statement

Cash from Operations (TTM) 337.25M
Cash from Investing (TTM) -411.17M
Cash from Financing (TTM) 912.87M

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.horizonpharma.com
  • Investor Relations URL: http://ir.horizon-pharma.com/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Feb. 26, 2021
  • Last Earnings Release: Nov. 02, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division. The majority of revenue is generated in the United States.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 68.91
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
JCNRX Janus Henderson Contrarian R 4.74%
PTH Invesco DWA Healthcare Momentum ETF 3.75%
WSMRX William Blair Small-Mid Cap Growth R6 3.28%
FXH First Trust Health Care AlphaDEX® ETF 1.69%
IBB iShares Nasdaq Biotechnology ETF 1.64%
HRAYX Carillon Eagle Mid Cap Growth Y 1.54%
HQH Tekla Healthcare Investors 1.34%
JGMCX Janus Henderson Triton C 1.27%
VISGX Vanguard Small Cap Growth Index Inv 0.91%
VBK Vanguard Small-Cap Growth ETF 0.91%
NAESX Vanguard Small Cap Index Inv 0.42%
VB Vanguard Small-Cap ETF 0.42%

Comparables

Edit
EBS Emergent BioSolutions Inc
PRGO Perrigo Co PLC
ALKS Alkermes PLC
JAZZ Jazz Pharmaceuticals PLC
ITRM Iterum Therapeutics PLC

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.